Xi Venture Capital and Zhaoyan New Drug jointly build a new cooperation platform worth 10 billion yuan 双语对照 笔记

　　On February 29th, Xichuang Capital, Zhaoyan New Drugs, and Huishan Science and Technology Innovation Industry Group signed a framework cooperation agreement to carry out in-depth cooperation in the form of "1+1+N", namely landing on "one platform", establishing "one fund", and introducing "N projects" to support and promote the research and industrialization process of synthetic biology, medical equipment, future food, etc., empowering the future development of Wuxi's health industry.

　　This strategic cooperation is another important layout for Xi Venture Capital's investment in the field of biomedicine. It has created a new cooperation platform with Zhaoyan New Drug, introducing Zhaoyan and its upstream and downstream enterprises in the industry chain to Wuxi through equity investment, and gathering industrial resources to advantageous enterprises through market-oriented means. It fully leverages the synergistic advantages of "industry+capital" to support and promote the research and industrialization process of biomedicine in Wuxi.